Applied Therapeutics Inc.

NASDAQ: APLT · Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM

Applied Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
79.4M 49.9M 16.66M 53.89M
Short-Term Investments
n/a n/a 13.92M 26.93M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
253K n/a n/a n/a
Receivables
n/a 285K 275K 525K
Inventory
n/a n/a -275K -525K
Other Current Assets
461K 920K 1.8M 2.09M
Total Current Assets
83.65M 54.39M 37.31M 88.39M
Property-Plant & Equipment
2.79M 447K 1.05M 1.5M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
3.04M 447K 1.05M 1.5M
Total Assets
86.69M 54.83M 38.36M 89.89M
Account Payables
4.43M 1.74M 4.53M 9.46M
Deferred Revenue
212K 667K n/a 15.57M
Short-Term Debt
406K 310K 477K 442K
Other Current Liabilities
18.23M 65.97M 25.64M 4.11M
Total Current Liabilities
27.3M 71.18M 33.42M 26.46M
Long-Term Debt
2.39M n/a 414K 891K
Other Long-Term Liabilities
n/a 759K 50K -891K
Total Long-Term Liabilities
2.39M 797K 878K 891K
Total Liabilities
29.68M 71.98M 34.3M 27.35M
Total Debt
2.79M 777K 891K 1.33M
Common Stock
35K 8K 5K 3K
Retained Earnings
-574.21M -468.59M -348.82M -266.31M
Comprehensive Income
n/a n/a 51K -107K
Shareholders Equity
57.01M -17.15M 4.06M 62.54M
Total Investments
n/a n/a 13.92M 26.93M